Navigation Links
Bausch + Lomb Acquires Option to License New Compound to Treat Dry Eye Syndrome (DES)
Date:7/18/2013

critical role in the protection and overall health of the ocular surface. Mucins are essential for lubrication; the removal of allergens, pathogens, and debris; and corneal epithelial healing to reduce ocular surface damage.  In addition, MIM-D3 may have additional benefits than currently available dry eye therapies including the potential to improve neural function, which may improve corneal sensitivity and integrity.7  

Phase 2 study results for MIM-D3 demonstrated that the use of MIM-D3, dosed twice a day, results in consistent improvements across multiple dry eye signs and symptoms with no safety or tolerability issues.  A Phase 3 study is scheduled to begin before the end of 2013, which will be conducted by Ora, Inc.

"Bausch + Lomb is committed to delivering effective ophthalmic therapeutic solutions for eye care professionals and their patients, and dry eye represents a significant unmet need," said Cal Roberts, M.D., chief medical officer, Bausch + Lomb. "Given the promising results of the Phase 2 studies, we are excited about the potential  of giving eye care professionals a new choice for treating one of the most common and bothersome eye conditions."

If approved, the new technology would dramatically expand Bausch + Lomb's ability to compete in a $2.5 billion global dry eye market growing at 10 percent annually,8 while creating an opportunity to explore expanded ophthalmic applications.

"Bausch + Lomb and Mimetogen share a commitment to developing new and effective therapies that address unmet medical needs," said Garth Cumberlidge, Ph.D., president and chief executive officer, Mimetogen Pharmaceuticals. "We are thrilled to be working with such a respected partner as Bausch + Lomb. The company's commitment to innovation, expertise and resources, combined with its global reach and powerful
'/>"/>

SOURCE Bausch + Lomb
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bausch + Lomb distribuirá lentes trifocais difractivas e intraoculares tóricas da PhysIOL nos principais mercados asiáticos, europeus e do oriente médio
2. Leica Microsystems and Bausch + Lomb Sign Global Agreement for Surgical Operating Microscopes
3. Bausch + Lomb soumet une déclaration denregistrement pour un projet doffre publique initiale
4. Bausch + Lomb Files Registration Statement For Proposed Initial Public Offering
5. Bausch + Lomb ernennt Robert Bertolini zum Präsident und Chief Financial Officer
6. Bausch + Lomb designa a Robert Bertolini presidente y CFO
7. Bausch + Lomb nomme Robert Bertolini président et directeur financier
8. Bausch + Lomb Names Robert Bertolini President And Chief Financial Officer
9. Bausch + Lomb und CROMA spenden dringend benötigte Augentropfen
10. Bausch + Lomb Product, Platform and Pipeline Innovations on Display at the Annual Meeting of the American Academy of Ophthalmology
11. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, 2014 ... ;  Sorrento), an oncology company developing new treatments ... a privately-held immuno-oncology company developing proprietary Neukoplast ® ... therapy, announced today that the companies have entered ... generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for the ...
(Date:12/19/2014)... 18, 2014 Research and Markets ... the "Micro Market Monitor: North American Dermatology ... http://photos.prnewswire.com/prnh/20130307/600769 ... steadily, which has resulted in fueling the overall ... main purpose of these dermatology devices is to ...
(Date:12/19/2014)... CITY, Calif., Dec. 18, 2014 Capnia, ... the development of medical diagnostics based on its ... gas flow, today announced financial results for the ... 2014. "Following the completion of our ... positioned to maximize the recently initiated CoSense® commercial ...
Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8
(Date:12/19/2014)... (PRWEB) December 19, 2014 From November 24, ... teacher training for the year 2014 in its Goa ... this year. Through the Indian winters, from November to March, ... the beautiful beach of Arambol, Goa. The Goa training sessions ... previous intakes of yoga teacher training, the 10th intake is ...
(Date:12/19/2014)... Dallas, TX (PRWEB) December 19, 2014 ... current state of the global Gliquidone industry with a ... statistics on the market status of the Gliquidone manufacturers ... for companies and individuals interested in the industry. , ... industry including its definition, applications and manufacturing technology. Then, ...
(Date:12/19/2014)... 18, 2014 (HealthDay News) -- Being in good shape seems ... They looked at data from more than 57,000 Americans, ... treadmill tests between 1991 and 2009. Those in the ... having high blood pressure at the start of the study, ... levels of fitness. Of the more than 8,000 people ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, ... exposed to high levels of air pollution late in pregnancy ... study suggests. Researchers found that of nearly 1,800 U.S. ... to the most air pollution during pregnancy were twice as ... exposure during the third trimester, specifically, showed the strongest correlation ...
(Date:12/19/2014)... News) -- Prostaglandin analogue eye drops -- a common ... of vision loss in patients with the eye disease, ... David Garway-Heath, of the Moorfields Eye Hospital and UCL ... than 500 people newly diagnosed with open-angle glaucoma -- ... of the leading causes of blindness. About 45 ...
Breaking Medicine News(10 mins):Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 2Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 4Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 5Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 6Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2
... uncertainty about risks and benefits of mastectomies or lumpectomies. ... the women diagnosed with early-stage breast cancer clearly understand ... breast-conserving lumpectomy plus radiation, even after they have one ... If the woman is black or Hispanic, the chances ...
... CNS Response,Inc. (OTC Bulletin Board: CNSO) ... roll out referenced-EEG(R) (rEEG(R)) availability with an,undisclosed, ... enables psychiatrists under the management of the ... to treat their most,therapy-challenged patients suffering any ...
... LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider of ... the opening of its 76th LasikPlus(R) vision,center in ... vision center opened this year, and the second ... a LasikPlus(R) vision,center in Paramus in April 2006., ...
... surgeons precise fingertip power control during laparoscopic procedures while, ... first in ... the healthcare industry, BOULDER, ... unique opportunity to offer surgeons greater control,and precision during surgeries ...
... 31 Ingenuity Systems, the,leading provider of ... that Path Designer, the new pathway publishing ... Best New Product by the scientific community ... San Francisco. Path,Designer enables researchers to create ...
... the United States face strikingly high levels of stigma, according ... AIDS Research. , The amfAR survey results will be ... 9 a.m. at the National Press Clubs 13th Floor First ... The press conference will be followed by a briefing in ...
Cached Medicine News:Health News:Many Women Unclear About Breast Cancer Treatments 2Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 2Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 3Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 4Health News:LCA-Vision Announces the Opening of its 76th LasikPlus(R) Vision Center in Woodbridge, New Jersey 2Health News:Encision Moves Power and Safety to Surgeons' Fingertips 2Health News:Ingenuity's Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference 2Health News:Ingenuity's Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference 3Health News:Stigma clings stubbornly to women living with HIV/AIDS 2Health News:Stigma clings stubbornly to women living with HIV/AIDS 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: